Literature DB >> 2328391

Characterization of presynaptic vascular muscarinic receptors inhibiting endogenous noradrenaline overflow in the portal vein of the freely moving rat.

R Remie1, R P Coppes, H Meurs, A F Roffel, J Zaagsma.   

Abstract

1. In the portal vein of permanently cannulated, freely moving, unanaesthetized rats, methacholine (MCh) is able to inhibit the electrically-evoked endogenous noradrenaline (NA) overflow. This inhibition is mediated by presynaptic inhibitory muscarinic heteroreceptors. 2. By use of pirenzepine, 4-diphenylacetoxy-N-methylpiperidine methobromide (4-DAMP) and AF-DX 116 as M1-, M3-, and M2-selective antagonists respectively, the MCh (0.1 microM)-induced inhibition of the electrically-evoked NA overflow could be reversed to the control stimulation value dose-dependently. 3. The potency order of the antagonists was: 4-DAMP greater than AF-DX 116 greater than pirenzepine, pIC50 values being 8.50, 7.96 and 7.01, respectively. 4. From these results it was concluded that the inhibitory presynaptic heteroreceptors in the portal vein of conscious unrestrained rats are of the cardiac M2-subtype.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2328391      PMCID: PMC1917397          DOI: 10.1111/j.1476-5381.1990.tb14684.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  Pronounced facilitation of endogenous noradrenaline release by presynaptic beta 2-adrenoceptors in the vasculature of freely moving rats.

Authors:  R Remie; H J Knot; H J Kolker; J Zaagsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-09       Impact factor: 3.000

2.  A new technique for the study of vascular presynaptic receptors in freely moving rats.

Authors:  R Remie; J Zaagsma
Journal:  Am J Physiol       Date:  1986-08

3.  Cardioselective profile of AF-DX 116, a muscarine M2 receptor antagonist.

Authors:  A Giachetti; R Micheletti; E Montagna
Journal:  Life Sci       Date:  1986-05-05       Impact factor: 5.037

4.  Selectivity of muscarinic antagonists in radioligand and in vivo experiments for the putative M1, M2 and M3 receptors.

Authors:  H N Doods; M J Mathy; D Davidesko; K J van Charldorp; A de Jonge; P A van Zwieten
Journal:  J Pharmacol Exp Ther       Date:  1987-07       Impact factor: 4.030

5.  Muscarinic M2 receptors in bovine tracheal smooth muscle: discrepancies between binding and function.

Authors:  A F Roffel; C R Elzinga; R G Van Amsterdam; R A De Zeeuw; J Zaagsma
Journal:  Eur J Pharmacol       Date:  1988-08-09       Impact factor: 4.432

Review 6.  Muscarinic receptor subtypes: a critique of the current classification and a proposal for a working nomenclature.

Authors:  R M Eglen; R L Whiting
Journal:  J Auton Pharmacol       Date:  1986-12

Review 7.  Local modulation of adrenergic neurotransmission in blood vessels.

Authors:  J T Shepherd; P M Vanhoutte
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

8.  Prejunctional inhibition of norepinephrine release caused by acetylcholine in the human saphenous vein.

Authors:  D K Rorie; N J Rusch; J T Shepherd; P M Vanhoutte; G M Tyce
Journal:  Circ Res       Date:  1981-08       Impact factor: 17.367

9.  A comparison of the antimuscarinic effects of pirenzepine and N-methylatropine on ganglionic and vascular muscarinic receptors in the rat.

Authors:  J Wess; G Lambrecht; U Moser; E Mutschler
Journal:  Life Sci       Date:  1984-07-30       Impact factor: 5.037

10.  Presynaptic regulation of the release of catecholamines.

Authors:  S Z Langer
Journal:  Pharmacol Rev       Date:  1980-12       Impact factor: 25.468

View more
  3 in total

1.  Presynaptic muscarinic receptor subtypes involved in the inhibition of acetylcholine and noradrenaline release in bovine cerebral arteries.

Authors:  M Ferrer; R Galván; J Marín; G Balfagón
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-06       Impact factor: 3.000

2.  Prejunctional muscarine receptors in the rabbit ear artery differ from M1, M2 and M3 muscarine receptors.

Authors:  S A Darroch; L K Choo; F Mitchelson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-03       Impact factor: 3.000

3.  NMDA receptors in the rat VTA: a critical site for social stress to intensify cocaine taking.

Authors:  Herbert E Covington; Thomas F Tropea; Anjali M Rajadhyaksha; Barry E Kosofsky; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2007-12-19       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.